Soludent
The computed 12-month bankruptcy probability of Soludent is 0.2% (very low). The 2025 annual accounts show equity of €297k and a net result of €148k. Equity is growing by ~88.6% per year across the filed fiscal years. Its solvency ranks better than 36% of 86 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €297k |
| Net result | €148k |
| Better than sector | 36% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 33.4% | 56.8% | |
| Net result | €148k | €97k | |
| Equity | €297k | €202k | |
| Gross operating margin | €223k | €237k | |
| Total assets | €889k | €576k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €148k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | €43k |
| Dividends | - |
| Total assets | €889k |
| Equity | €297k |
| Debt | €77k |
| of which ≤ 1y | €77k |
| of which > 1y | - |
| Working capital | €287k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 4.72 |
| Quick ratio | 4.72 |
| Working capital ratio | 32.3% |
| Solvency | 33.4% |
| Debt / equity | 0.26 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 16.7% |
| ROE | 50.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €889k |
| Fixed assets | 21/28 | €525k |
| Financial fixed assets | 28 | €525k |
| Current assets | 29/58 | €364k |
| Investments | 50/53 | €300k |
| Cash & bank | 54/58 | €63k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €889k |
| Equity | 10/15 | €297k |
| Contributions / capital | 10/11 | €10k |
| Accumulated profits (losses) | 14 | €287k |
| Provisions & deferred taxes | 16 | €515k |
| Amounts payable | 17/49 | €77k |
| Amounts payable within one year | 42/48 | €77k |
| Income statement | ||
| Gross operating margin | 9900 | €223k |
| Operating result | 9901 | €223k |
| Financial income | 75 | €1k |
| Financial charges | 65 | €33k |
| Result before taxes | 9903 | €191k |
| Income taxes | 67/77 | €43k |
| Net result for the period | 9904 | €148k |
| Result to be appropriated | 9905 | €148k |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 05-05-2023 |
| Status | Active |
| Postal code | 2880 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12362E0028/00K002 | Flanders | 536 m² | 1 · 129 m² | 3.6 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-03-2026 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-06",
"filing_date": "2026-02-26",
"act_kind_objet": "Neerlegging fusievoorstel (overname van LTH S. DE BRUYNE BV door Soludent BV)"
},
"key_dates": [
{
"date": "2026-03-06",
"label": "Publicatie datum"
},
{
"date": "2026-02-26",
"label": "Neergelegd"
},
{
"date": "2023-05-05",
"label": "Opgericht"
},
{
"date": "2023-05-09",
"label": "Gepubliceerd"
},
{
"date": "2008-03-14",
"label": "Opgericht"
},
{
"date": "2008-04-03",
"label": "Gepubliceerd"
},
{
"date": "2026-01-01",
"label": "Boekhoudkundige peildatum"
},
{
"date": "2026-06-30",
"label": "Streefdatum goedkeuring fusie"
}
],
"key_parties": [
{
"kbo": "0896631475",
"kind": "org",
"name": "LTH S. DE BRUYNE BV",
"role": "Overgenomen vennootschap"
},
{
"kind": "person",
"name": "Sofie Tierens",
"role": "Bestuurder"
},
{
"kind": "person",
"name": "Sabine De Bruyne",
"role": "Bestuurder"
},
{
"kind": "org",
"name": "Vereycken \u0026 Vereycken Accounting BV",
"role": "Vermachtnemer"
}
],
"key_amounts_eur": [],
"subject_company": {
"kbo": "0801.505.753",
"name_full": "Soludent",
"legal_form": "BV"
},
"publication_proxy": {
"kind": null
},
"summary_narrative": "",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal"
}09-05-2023 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Barelstraat 100 bus 001, 2880 Bornem",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1997-02-13",
"name": "TIERENS Sofie Agnes Karel",
"niss": null,
"address": "Barelstraat 98, 2880 Bornem"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 10000,
"holder_person_name": "TIERENS Sofie Agnes Karel",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 10000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 10000,
"subject_company": {
"kbo": "0801.505.753",
"name_full": "Soludent",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2023-05-05",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Soludent |